Literature DB >> 15810079

Effects of STI571 and p27 gene clone on proliferation and apoptosis of K562 cells.

Wei Wang1, Li-Bo Yao, Xin-Ping Liu, Qi Feng, Zhen-Chuan Shang, Yun-Xin Cao, Bing-Zhong Sun.   

Abstract

AIM: To investigate the combined effect of STI571 and p27 gene clone on the regulation of proliferation, cell cycle and apoptosis of K562 cell line.
METHODS: p27 gene was obtained by RT-PCR, and its sequence was approved to be correct. Then p27-pcDNA3.1 vector was constructed and transfected into K562 cell line. p27-pcDNA3.1-K562 cell clone was screened by G418 after transfection, p27 protein was identified by Western blot. MTT was used to detect the survival rate of the cell. Flow cytometry was used to detect cell cycle and apoptosis index.
RESULTS: The expression of p27 protein could be detected by Western blot in p27-pcDNA3.1-K562 cells. A strong inhibition of cell proliferation was observed in p27-pcDNA3.1-K562 cells as compared with that of the control (pcDNA3.1-K562 cells). The cells at G0/G1 phase were significantly increased, and cells at S phase were greatly declined. The apoptosis index was increased greatly after p27-pcDNA3.1-K562 cells were treated with STI571, and survival rate of the cell was markedly declined (0.35-0.58, P<0.05-0.048 vs STI571-K562 cell, 0.35-0.72, P<0.01-0.001 vs p27-K562 cell).
CONCLUSION: p27 and STI571 have a synergistic action on inhibition of proliferation and induction of apoptosis on K562 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810079      PMCID: PMC4305782          DOI: 10.3748/wjg.v11.i14.2130

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  [Cell cycle and checkpoints in oncology: new therapeutic targets].

Authors:  Yves Pommier; Kurt W Kohn
Journal:  Med Sci (Paris)       Date:  2003-02       Impact factor: 0.818

2.  The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

Authors:  C Caslini; A Shilatifard; L Yang; J L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.

Authors:  M Schreiber; W J Muller; G Singh; F L Graham
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

4.  Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

Authors:  T G Lugo; A M Pendergast; A J Muller; O N Witte
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

5.  Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.

Authors:  G P Amarante-Mendes; C Naekyung Kim; L Liu; Y Huang; C L Perkins; D R Green; K Bhalla
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

6.  Proteasome-dependent degradation of p27/kip1 in gliomas.

Authors:  R Piva; I Cancelli; P Cavalla; S Bortolotto; J Dominguez; G F Draetta; D Schiffer
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

7.  The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.

Authors:  S D Patel; A C Tran; Y Ge; M Moskalenko; L Tsui; G Banik; W Tom; M Scott; L Chen; M Van Roey; M Rivkin; M Mendez; J Gyuris; J G McArthur
Journal:  Mol Ther       Date:  2000-08       Impact factor: 11.454

8.  Bcr - Abl-mediated resistance to apoptosis is independent of PI 3-kinase activity.

Authors:  G P Amarante-Mendes; T Jascur; W K Nishioka; T Mustelin; D R Green
Journal:  Cell Death Differ       Date:  1997-10       Impact factor: 15.828

9.  Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.

Authors:  Eric C McGary; Amir Onn; Lisa Mills; Amy Heimberger; Omar Eton; Gary W Thomas; Mikhail Shtivelband; Menashe Bar-Eli
Journal:  J Invest Dermatol       Date:  2004-02       Impact factor: 8.551

10.  Effects of STI571 (gleevec) on pancreatic cancer cell growth.

Authors:  Junsheng Li; Jörg Kleeff; Junchao Guo; Lars Fischer; Nathalia Giese; Markus W Büchler; Helmut Friess
Journal:  Mol Cancer       Date:  2003-09-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.